Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)
Alzheimer's Drug-Development Program (U01 Clinical Trial Optional) is a published development and funding opportunity on Contexium. The donor or funder is National Institutes of Health. Project location(s): United States. Applications close on 05 Nov 2027. Budget: 1,500,000 USD. The goal of this Notice of Funding Opportunity (NOFO) is to provide funding support for the pre-clinical and early stage clinical (Phase I) development of novel small-molecule and biologic drug candidates that prevent Alzheimer's disease (AD), slow its progression, or treat its cognitive and behavio…
Opportunity overview
- Project name
- Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)
- Donor
- National Institutes of Health
Key details
- Opportunity start date
- Opportunity end date
- Project location(s)
- United States
- Budget
- 1,500,000
- Currency
- US Dollar
Summary
Frequently asked questions
What is Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)?
Alzheimer's Drug-Development Program (U01 Clinical Trial Optional) is a published development and funding opportunity on Contexium. The donor or funder is National Institutes of Health. Project location(s): United States. Applications close on 05 Nov 2027. Budget: 1,500,000 USD. The goal of this Notice of Funding Opportunity (NOFO) is to provide funding support for the pre-clinical and early stage clinical (Phase I) development of novel small-molecule and biologic drug candidates that prevent Alzheimer's disease (AD), slow its progression, or treat its cognitive and behavio…
Who is funding Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)?
Alzheimer's Drug-Development Program (U01 Clinical Trial Optional) is funded by National Institutes of Health.
When is the deadline to apply for Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)?
The application deadline is 05 Nov 2027 00:00 (UTC).
Where will the Alzheimer's Drug-Development Program (U01 Clinical Trial Optional) project take place?
The project location(s) are: United States.
What is the budget for Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)?
The available budget is 1,500,000 USD.
How can I apply for Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)?
Create a free Contexium account to view the full opportunity details and submit an application via the marketplace.